Cocrystal Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
20.38
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.48
|
-0.70
|
-0.22
|
-45.83%
|
|
2022-06-30
|
-0.52
|
-3.00
|
-2.48
|
-476.92%
|
|
2022-03-31
|
-0.42
|
-0.48
|
-0.06
|
-14.29%
|
|
2021-12-31
|
-0.48
|
-0.48
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.48
|
-0.48
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.42
|
-0.48
|
-0.06
|
-14.29%
|
|
2021-03-31
|
-0.54
|
-0.48
|
0.06
|
11.11%
|
|
2020-12-31
|
-0.48
|
-0.24
|
0.24
|
50.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.18
|
|
2021-12-31
|
-1.92
|
|
2020-12-31
|
-0.96
|
|
2019-12-31
|
0.18
|
|
2018-12-31
|
0.17
|
|
2017-12-31
|
-0.03
|
|
2016-12-31
|
-3.15
|
|
2015-12-31
|
-2.58
|
|
2014-12-31
|
-3.75
|